abstract |
Disclosed herein are agonistic anti-CD40 antibodies and methods of using such for eliciting CD40 signaling, thereby enhancing immune responses, such as dendritic cell functions. The antibodies disclosed within may be used to treat diseases, such as cancer and immune disorders. |